Fate Therapeutics Inc FATE:NASDAQ

Last Price$18.99Cboe Previous Close - Real-Time Last Sale as of 4:00PM ET 8/19/19
Cboe Real-Time Quotes
Today's Change0.00(0.00%)
Bid (Size)$18.55 (100)
Ask (Size)$19.04 (200)
Day Low / High$18.37 - 19.34
Volume616.2 K
  • Latest Stories
  • Commentary and Analysis
--Analyst Actions: BTIG Research Initiates Coverage on Fate Therapeutics at Buy, PT $27
11:50AM ET 8/09/2019 MT Newswires

Price: 18.44, Change: -0.81, Percent Change: -4.21 ...

--Analyst Actions: Wedbush Raises Price Target on Fate Therapeutics to $26 From $21, Maintains Outperform
8:09AM ET 8/07/2019 MT Newswires

Price: 19.82, Change: +0.55, Percent Change: +2.85 ...

Significant Insider Selling Continues at Fate Therapeutics (FATE)
10:17PM ET 8/05/2019 MT Newswires

There was a notable sale of shares of Fate Therapeutics by an insider today, as revealed in a form 4 document filed with the SEC. One insider -- Dr Amir...

Insider Trends: Fate Therapeutics Insider Extends 90-Day Selling Trend
4:34PM ET 8/02/2019 MT Newswires

On Jul 31, 2019, Director, Dr Amir Nashat, executed a sale of 62,005 shares in Fate Therapeutics (FATE) for $1,397,066. Dr Nashat, after the transactions...

Continued Level of Significant Insider Selling at Fate Therapeutics (FATE)
10:18PM ET 7/31/2019 MT Newswires

There was a substantial sale of shares of Fate Therapeutics by an insider today, as revealed in a form 4 document filed with the SEC. One insider -- Dr...

Insider Trends: Insider Adds to Selling Trend at Fate Therapeutics
6:27PM ET 7/30/2019 MT Newswires

Dr Amir Nashat, Director, reported a sale of 118,333 shares in Fate Therapeutics (FATE) on Jul 26, 2019, for $2,663,115. Dr Nashat, following the...

Significant Insider Selling in Shares of Fate Therapeutics (FATE) Continues
10:17PM ET 7/26/2019 MT Newswires

A substantial insider sale of the shares of Fate Therapeutics was disclosed in a form 4 document filed with the SEC today, showing -- Dr Amir Nashat,...

Insider Trends: 90-Day Insider Selling Trend Prolonged at Fate Therapeutics
6:25PM ET 7/25/2019 MT Newswires

Dr Amir Nashat, Director, sold 81,899 shares of Fate Therapeutics (FATE) on Jul 23, 2019, for $1,843,151. Subsequent to the Form 4 filing with the SEC, Dr...

Insider Makes Significant Stock Sells in Fate Therapeutics (FATE) Shares
10:17PM ET 7/23/2019 MT Newswires

One insider -- Dr Amir Nashat, Director -- today, disposed of 71,166 shares of Fate Therapeutics having a market value of approximately $1,602,506, as...

Insider Trends: Insider 90-Day Selling Trend Prolonged at Fate Therapeutics
5:54PM ET 7/22/2019 MT Newswires

Dr Amir Nashat, Director, sold 71,166 shares in Fate Therapeutics (FATE) for $1,602,506 on Jul 18, 2019. Following the Form 4 filing with the SEC, Dr...